TScan Therapeutics announced the appointment of Dawn Pinchasik, M.D., M.S., as Vice President, VP, Clinical Development. Dr. Pinchasik brings to TScan over a decade of experience in clinical development across the pharmaceutical and biotechnology industry. Prior to joining TScan, Dr. Pinchasik was the Senior Director, Early Development at ElevateBio, LLC, where she supported the internal pipeline and partnered programs for ElevateBio and the wholly owned subsidiary, Life Edit Therapeutics Inc.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on TCRX:
- TScan Therapeutics Expands Clinical Team with the Appointment of Dawn Pinchasik, M.D., M.S., as Vice President, Clinical Development
- TScan Therapeutics Welcomes Jason Amello as New CFO
- TScan Therapeutics Appoints Seasoned Industry Executive Jason A. Amello as Chief Financial Officer
- TScan Therapeutics appoints Amello as Chief Financial Officer
- TScan Therapeutics Announces Best Abstracts Award and Upcoming Oral Presentation at the 2024 Tandem Meetings of ASTCT and CIBMTR